Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recurrence After Robotic eTEP Incisional Hernia Repair Emerges Beyond 24 Months: A Consecutive Series Challenging Short-Term Outcome Reporting.

Created on 18 Nov 2026

Authors

Francesca Da Canal, Tullio A V Facchini, Claudine Di Pietro Martinelli, Walter Gantert, Georgios Peros, Ioannis I Lazaridis, Tarik Delko

Published in

Surgical laparoscopy, endoscopy & percutaneous techniques. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

Most published robotic enhanced-view totally extraperitoneal (eTEP) hernia repair series report follow-up under 12 months and recurrence rates of 1% to 3%.
We retrospectively analyzed 65 consecutive patients undergoing robotic eTEP incisional hernia repair at a single center (2019 to 2025; Da Vinci Xi system); recurrence-free survival was estimated by the Kaplan-Meier method.
Median follow-up was 27.9 months (range: 11.7-76.2). The overall recurrence rate was 4/65 (6.2%); all 4 recurrences occurred in patients with follow-up ≥24 months (4/41, 9.8%), with none before 24 months. Kaplan-Meier recurrence-free survival was 97.1% (95% CI: 91.8-100%) at 36 and 48 months. Primary fascial closure was achieved in 100% of cases, and the short-term complication rate was 9.2% (Clavien-Dindo grade I-II only).
Because all recurrences emerged beyond 24 months, follow-up periods shorter than 24 months may fail to detect late clinical recurrences after eTEP repair.

PMID:
43044050
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement